epha3 py779 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
93
Structured Review
Cell Signaling Technology Inc
epha3 py779
Epha3 Py779, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/epha3+py779/Phospho-EphA3+(Tyr779)+Rabbit+mAb/10__1016_slash_j__jbc__2021__100876-303-87-89
Average 93 stars, based on 9 article reviews
Epha3 Py779, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/epha3+py779/Phospho-EphA3+(Tyr779)+Rabbit+mAb/10__1016_slash_j__jbc__2021__100876-303-87-89
Average 93 stars, based on 9 article reviews
epha3 py779 - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Incubation:Article Title: A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain Article Snippet: Lysates, pull-downs and immunoprecipitations were run on Bolt 4-12% Bis-Tris Plus gels (Invitrogen, NW04125). .. After semi-dry transfer, the immobilon membranes were blocked with 5% bovine serum albumin in 0.1% Tween-20 in TBS (150 mM NaCl, 50 mM TrisHCl pH 7.5) for 1 hour and then incubated overnight at 4°C in blocking buffer containing primary antibodies recognizing EphA4 (BD Biosciences, 610471; 1:1,000; Figs. 1D, 2A-C, 4B and 7A), an affinitypurified rabbit polyclonal EphA4 antibody generated using a peptide corresponding the the 11 C- terminal amino acids of human and mouse EphA4 (76) and used at 1 g/ml in Figs. 2D and 4A); Article Title: A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain Article Snippet: Lysates, pull-downs, and immunoprecipitations were run on Bolt 4 to 12% Bis-Tris Plus gels (Invitrogen, NW04125). .. After semidry transfer, the immobilon membranes were blocked with 5% bovine serum albumin in 0.1% Tween-20 in TBS (150 mM NaCl, 50 mM TrisHCl pH 7.5) for 1 h and then incubated overnight at 4 °C in blocking buffer containing primary antibodies recognizing EphA4 (BD Biosciences, 610471; 1:1000; D , , A – C , B and A , an affinity-purified rabbit polyclonal EphA4 antibody generated using a peptide corresponding to the 11 C-terminal amino acids of human and mouse EphA4 ( ) and used at 1 μg/ml in D and A ); Blocking Assay:Article Title: A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain Article Snippet: Lysates, pull-downs and immunoprecipitations were run on Bolt 4-12% Bis-Tris Plus gels (Invitrogen, NW04125). .. After semi-dry transfer, the immobilon membranes were blocked with 5% bovine serum albumin in 0.1% Tween-20 in TBS (150 mM NaCl, 50 mM TrisHCl pH 7.5) for 1 hour and then incubated overnight at 4°C in blocking buffer containing primary antibodies recognizing EphA4 (BD Biosciences, 610471; 1:1,000; Figs. 1D, 2A-C, 4B and 7A), an affinitypurified rabbit polyclonal EphA4 antibody generated using a peptide corresponding the the 11 C- terminal amino acids of human and mouse EphA4 (76) and used at 1 g/ml in Figs. 2D and 4A); Article Title: A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain Article Snippet: Lysates, pull-downs, and immunoprecipitations were run on Bolt 4 to 12% Bis-Tris Plus gels (Invitrogen, NW04125). .. After semidry transfer, the immobilon membranes were blocked with 5% bovine serum albumin in 0.1% Tween-20 in TBS (150 mM NaCl, 50 mM TrisHCl pH 7.5) for 1 h and then incubated overnight at 4 °C in blocking buffer containing primary antibodies recognizing EphA4 (BD Biosciences, 610471; 1:1000; D , , A – C , B and A , an affinity-purified rabbit polyclonal EphA4 antibody generated using a peptide corresponding to the 11 C-terminal amino acids of human and mouse EphA4 ( ) and used at 1 μg/ml in D and A ); Generated:Article Title: A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain Article Snippet: Lysates, pull-downs and immunoprecipitations were run on Bolt 4-12% Bis-Tris Plus gels (Invitrogen, NW04125). .. After semi-dry transfer, the immobilon membranes were blocked with 5% bovine serum albumin in 0.1% Tween-20 in TBS (150 mM NaCl, 50 mM TrisHCl pH 7.5) for 1 hour and then incubated overnight at 4°C in blocking buffer containing primary antibodies recognizing EphA4 (BD Biosciences, 610471; 1:1,000; Figs. 1D, 2A-C, 4B and 7A), an affinitypurified rabbit polyclonal EphA4 antibody generated using a peptide corresponding the the 11 C- terminal amino acids of human and mouse EphA4 (76) and used at 1 g/ml in Figs. 2D and 4A); Article Title: A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain Article Snippet: Lysates, pull-downs, and immunoprecipitations were run on Bolt 4 to 12% Bis-Tris Plus gels (Invitrogen, NW04125). .. After semidry transfer, the immobilon membranes were blocked with 5% bovine serum albumin in 0.1% Tween-20 in TBS (150 mM NaCl, 50 mM TrisHCl pH 7.5) for 1 h and then incubated overnight at 4 °C in blocking buffer containing primary antibodies recognizing EphA4 (BD Biosciences, 610471; 1:1000; D , , A – C , B and A , an affinity-purified rabbit polyclonal EphA4 antibody generated using a peptide corresponding to the 11 C-terminal amino acids of human and mouse EphA4 ( ) and used at 1 μg/ml in D and A ); FLAG-tag:Article Title: A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain Article Snippet: Lysates, pull-downs and immunoprecipitations were run on Bolt 4-12% Bis-Tris Plus gels (Invitrogen, NW04125). .. After semi-dry transfer, the immobilon membranes were blocked with 5% bovine serum albumin in 0.1% Tween-20 in TBS (150 mM NaCl, 50 mM TrisHCl pH 7.5) for 1 hour and then incubated overnight at 4°C in blocking buffer containing primary antibodies recognizing EphA4 (BD Biosciences, 610471; 1:1,000; Figs. 1D, 2A-C, 4B and 7A), an affinitypurified rabbit polyclonal EphA4 antibody generated using a peptide corresponding the the 11 C- terminal amino acids of human and mouse EphA4 (76) and used at 1 g/ml in Figs. 2D and 4A); Article Title: A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain Article Snippet: Lysates, pull-downs, and immunoprecipitations were run on Bolt 4 to 12% Bis-Tris Plus gels (Invitrogen, NW04125). .. After semidry transfer, the immobilon membranes were blocked with 5% bovine serum albumin in 0.1% Tween-20 in TBS (150 mM NaCl, 50 mM TrisHCl pH 7.5) for 1 h and then incubated overnight at 4 °C in blocking buffer containing primary antibodies recognizing EphA4 (BD Biosciences, 610471; 1:1000; D , , A – C , B and A , an affinity-purified rabbit polyclonal EphA4 antibody generated using a peptide corresponding to the 11 C-terminal amino acids of human and mouse EphA4 ( ) and used at 1 μg/ml in D and A ); Affinity Purification:Article Title: A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain Article Snippet: Lysates, pull-downs, and immunoprecipitations were run on Bolt 4 to 12% Bis-Tris Plus gels (Invitrogen, NW04125). .. After semidry transfer, the immobilon membranes were blocked with 5% bovine serum albumin in 0.1% Tween-20 in TBS (150 mM NaCl, 50 mM TrisHCl pH 7.5) for 1 h and then incubated overnight at 4 °C in blocking buffer containing primary antibodies recognizing EphA4 (BD Biosciences, 610471; 1:1000; D , , A – C , B and A , an affinity-purified rabbit polyclonal EphA4 antibody generated using a peptide corresponding to the 11 C-terminal amino acids of human and mouse EphA4 ( ) and used at 1 μg/ml in D and A ); |